In the high-stakes world of cardiovascular medicine, the ability to accurately distinguish between benign plaque buildup and...
Treatment Innovations
Cardiovascular disease (CVD) has long been categorized as the world’s most formidable silent killer. Responsible for an...
In a landmark shift for infectious disease management, AbbVie’s direct-acting antiviral (DAA) therapy, Maviret (glecaprevir/pibrentasvir), has secured...
In the high-stakes arena of neurotechnology and cellular research, the quest for clarity is perpetual. Every micron...
The Department of Health and Human Services (HHS) has officially opened the floor for nominations to the...
In an era where precision medicine is becoming the standard, the physical infrastructure of healthcare—specifically the delivery...
By Jacob Bell Published August 28, 2026 The biotechnology sector, often characterized by its volatile boom-and-bust cycles,...
As the pharmaceutical industry approaches a new frontier in neuropsychiatric care, Definium Therapeutics finds itself at a...
In a significant leap forward for cardiovascular medicine, Royal Philips and Imricor Medical Systems have officially launched...
The pharmaceutical and biotechnology sectors have entered a period of intense activity as fall approaches, marked by...
